Link to this page
Medical Subject Headings
| Preferred Name | Nivolumab | |
| Synonyms |
BMS-936558 BMS936558 Opdivo BMS 936558 MDX-1106 MDX 1106 ONO4538 ONO 4538 MDX1106 ONO-4538 |
|
| Definitions |
A genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077594 |
|
| altLabel |
BMS-936558 BMS936558 Opdivo BMS 936558 MDX-1106 MDX 1106 ONO4538 ONO 4538 MDX1106 ONO-4538
|
|
| AQL |
AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
|
|
| cui |
C4552119 C3872108 C2346820 C4552118 C3657270
|
|
| DC |
1
|
|
| definition |
A genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA.
|
|
| DX |
20190101
|
|
| HN |
2019 (2010)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000648 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000502 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000187 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000633 |
|
| Inverse of RB |
31YO63LBSN 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2019; NIVOLUMAB was indexed under ANTIBODIES, MONOCLONAL 2010-2018
|
|
| MDA |
20180709
|
|
| MMR |
20200228
|
|
| MN |
D12.776.124.790.651.114.224.060.829 D12.776.124.486.485.114.224.060.829 D12.776.377.715.548.114.224.200.829
|
|
| notation |
D000077594
|
|
| PA |
D000074322 D000082082
|
|
| prefLabel |
Nivolumab
|
|
| TERMUI |
T775640 T000875377 T000940418 T775642 T775641
|
|
| TH |
NLM (2015) USAN (19XX) INN (19XX) NLM (2013) NLM (2010) FDA SRS (2015)
|
|
| tui |
T116 T129 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |